Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human OSMR beta Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Supplier: R&D Systems™ 4389OR050
This item is not returnable.
View return policy
Description
The Recombinant Human OSM R beta Protein is derived from NS0. The Recombinant Human OSM R beta Protein has been validated for the following applications: Binding Activity.Specifications
Lyophilized from a 0.2μm filtered solution in PBS. | |
81 kDa | |
50μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Unconjugated | |
85%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
9180 | |
OSMR beta | |
Mouse myeloma cell line,NS0-derived human OSM R beta protein Glu28-Ser739 | |
IL-31 receptor subunit beta, IL-31R subunit beta, IL-31RB, IL-31R-beta, Interleukin-31 receptor subunit beta, MGC150627, MGC75127, oncostatin M receptor, oncostatin-M specific receptor beta subunit, oncostatin-M-specific receptor subunit beta, OSM R beta, OSMR, OSMRB, OSMRBMGC150626, PLCA1 | |
Recombinant |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction